Translational pharmacokinetic (PK), pharmacodynamic (PD) modeling and simulation analysis of MetMAb

被引：1
|
作者：
Bender, B. [1 ]
Xiang, H. [2 ]
Reyes, A. E., II [2 ]
Damico, L. A. [2 ]
Merchant, M. [3 ]
Peterson, A. [4 ]
Forrest, W. [5 ]
Jumbe, N. L. [1 ]
机构：
[1] Genentech Inc, Clin PKIPD, San Francisco, CA USA
[2] Genentech Inc, Early Dev PKIPD, San Francisco, CA USA
[3] Genentech Inc, Translat BioOncol, San Francisco, CA USA
[4] Genentech Inc, Clin BioOncol, San Francisco, CA USA
[5] Genentech Inc, NonClin Biostat, San Francisco, CA USA
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 12期
关键词：
D O I：
10.1016/S1359-6349(08)72473-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：170 / 170
页数：1
相关论文
共 50 条
  • [21] Pharmacokinetic and pharmacodynamic (PK/PD) evaluation of cefazolin in dog
    Cagnardi, P.
    Ravasio, G.
    Acocella, F.
    Villa, R.
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2015, 38 : 123 - 123
  • [22] Ciprofloxacin Inhale - A Pharmacokinetic(PK)/pharmacodynamic(PD) Rationale
    Stass, H.
    Dalhoff, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [23] RELEVANT KEY PHARMACOKINETIC (PK) AND PHARMACODYNAMIC (PD) GENES
    Malik, Salma
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2023, 62 (10): : S71 - S72
  • [24] PHARMACOKINETIC-PHARMACODYNAMIC (PK-PD) MODELING FOR METFORMIN IN HEALTHY VOLUNTEERS.
    Kim, Y.
    Cho, S.
    Lee, D.
    Son, H.
    Roh, H.
    Son, M.
    Heo, Y.
    Park, K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S48 - S48
  • [25] The science of erythropoicsis: Quantification of factors influencing response by pharmacokinetic (PK) and pharmacodynamic (PD) modeling
    Jumbe, NL
    Rossi, G
    Heatherington, AC
    Colowick, A
    BLOOD, 2002, 100 (11) : 9B - 9B
  • [26] Pharmacokinetic and Pharmacodynamic Evaluation of Marbofloxacin and PK/PD Modeling against Escherichia coli in Pigs
    Lei, Zhixin
    Liu, Qianying
    Xiong, Jincheng
    Yang, Bing
    Yang, Shuaike
    Zhu, Qianqian
    Li, Kun
    Zhang, Shishuo
    Cao, Jiyue
    He, Qigai
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [27] PHARMACOKINETIC-PHARMACODYNAMIC (PK-PD) MODELING OF MIDAZOLAM-FLUMAZENIL INTERACTIONS
    FISET, P
    EGAN, T
    LEMMENS, H
    SHAFER, S
    STANSKI, D
    ANESTHESIOLOGY, 1993, 79 (3A) : A362 - A362
  • [28] SIMULTANEOUS MATHEMATICAL-MODELING OF THE PHARMACOKINETIC (PK) AND PHARMACODYNAMIC (PD) PROPERTIES OF CEFOPERAZONE (CF)
    DUDLEY, MN
    ZINNER, SH
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (02) : 192 - 192
  • [29] Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling and simulation of oxaliplatin for hematological toxicity in rats
    Kobuchi, Shinji
    Katsuyama, Yosuke
    Ito, Yukako
    XENOBIOTICA, 2020, 50 (02) : 146 - 153
  • [30] POPULATION PHARMACOKINETIC/PHARMACODYNAMIC (PK/PD) MODELING AND SIMULATION FOR TIGULIXOSTAT, A NOVEL XANTHINE OXIDASE INHIBITOR FOR THE TREATMENT OF GOUT WITH HYPERURICEMIA
    Denney, W.
    Lee, M.
    Lee, N.
    Jun, H.
    Seo, J.
    Lee, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S69 - S69
12345